SCHEMBL16896882

SCHEMBL16896882

COc1cc2c(cc1-c1c(C)noc1C)OCC(=O)N2CCc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 2/20 0.42
▸ SLC5A1 P13866 8/20 0.42
▸ SLC5A2 P31639 8/20 0.42
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ EZH2 Q15910 2/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ BRD2 P25440 1/20 0.39
▸ BRD3 Q15059 1/20 0.39
▸ KMO O15229 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ HTR1A P08908 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16896942 0.92 L3MBTL1 (0.44) PIK3CGSLC5A1SLC5A2CYP3A4CYP2C9
SCHEMBL16896884 0.90 BRD4 (0.41) PIK3CGCYP3A4CYP2C9CYP2D6CYP2C19
SCHEMBL16896893 0.83 BRD4 (0.44) CYP3A4CYP2C9CYP2D6CYP2C19EZH2
SCHEMBL16896867 0.83 BRD4 (0.41) CYP3A4CYP2C9EZH2BRD4BRD2
SCHEMBL16896900 0.83 BRD4 (0.48) CYP3A4CYP2C9CYP2D6CYP2C19BRD4
SCHEMBL16897775 0.81 BRD4 (0.44) CYP3A4CYP2C9CYP2D6CYP2C19EZH2
SCHEMBL18317138 0.80 BRD4 (0.41) CYP3A4CYP2C9EZH2BRD4BRD2
SCHEMBL16896866 0.80 BRD4 (0.42) CYP3A4CYP2C9CYP2D6CYP2C19EZH2
SCHEMBL18317114 0.79 BRD4 (0.41) CYP3A4CYP2C9EZH2BRD4BRD2
SCHEMBL16896794 0.78 BRD4 (0.43) CYP3A4CYP2C9CYP2D6CYP2C19BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092227-A1 BICYCLIC HETEROCYCLIC DERIVATIVES AS BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2016-11-16 — — EP disclosed
WO-2015104653-A1 BICYCLIC HETEROCYCLIC DERIVATIVES AS BROMODOMAIN INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2015-07-16 — — WO disclosed
Send feedback